Diego Ossandon
Overview
Explore the profile of Diego Ossandon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garin J, Sampor C, Grigorovski N, Ceciliano A, Fandino A, Ossandon D, et al.
Pediatr Blood Cancer
. 2023 Apr;
70(7):e30352.
PMID: 37057832
Local therapies are increasingly used for ocular preservation in retinoblastoma. In middle-income countries, these techniques pose specific challenges mostly related to more advanced disease at diagnosis. The Grupo de America...
2.
Zanolli M, Oporto J, Verdaguer J, Lopez J, Zacharias S, Romero P, et al.
Ophthalmic Genet
. 2020 Mar;
41(1):36-40.
PMID: 32141364
: Inherited ocular conditions are a frequent cause of blindness. Gene therapy has encouraged the development of genetic testing, currently able to detect up to 80% of mutations in contrast...
3.
Fabian I, Abdallah E, Abdullahi S, Abdulqader R, Boubacar S, Ademola-Popoola D, et al.
JAMA Oncol
. 2020 Feb;
6(5):685-695.
PMID: 32105305
Importance: Early diagnosis of retinoblastoma, the most common intraocular cancer, can save both a child's life and vision. However, anecdotal evidence suggests that many children across the world are diagnosed...
4.
Perez V, Sampor C, Rey G, Parareda-Salles A, Kopp K, Dabezies A, et al.
JAMA Ophthalmol
. 2018 May;
136(7):747-752.
PMID: 29799944
Importance: Multi-institutional collaborative studies that include large patient populations for the management of retinoblastoma with histopathological risk factors could provide important information for patient management. Objective: To evaluate the implementation...
5.
Ossandon D, Zanolli M, Stevenson R, Agurto R, Ortiz P, Dotan G
J AAPOS
. 2018 Mar;
22(2):124-127.
PMID: 29535051
Purpose: To report the results of retinopathy of prematurity (ROP) screening by a telemedicine system in Chile and evaluate its usefulness for referring patients who require treatment. Methods: Premature infants...
6.
Ossandon D, Kastner A, Zanolli M, Solanes F, Perez V, Repetto G, et al.
J AAPOS
. 2016 Nov;
20(6):548-550.e1.
PMID: 27815188
We report the case of a 23-month-old girl with bilateral retinoblastoma that demonstrated absence of retinal lesions in one eye but had an isolated white tumor in the posterior chamber....
7.
Ossandon D, Zanolli M, Perez V, Zuniga P, Belmar A, Varas M, et al.
J AAPOS
. 2014 Dec;
18(6):617-9.
PMID: 25448150
Intra-arterial chemotherapy (IAC) has proved to be an effective treatment for retinoblastoma, but can be very expensive in developing countries. We report 2 patients from Chile in whom IAC resulted...
8.
Lopez J, Ossandon D, Miller P, Sanchez L, Winter A
J AAPOS
. 2009 Aug;
13(4):413-4.
PMID: 19683195
Tuberous sclerosis is a multisystem autosomal-dominant disease characterized by hamartomatous growths in the brain, skin, kidneys, eyes, and heart, but it may affect almost any organ. Retinal hamartomas are 1...